TiGenix to be Acquired by Takeda Pharmaceutical, Stocks Soars by 70%
TiGenix (NASDAQ:TIG) has joined the ranks of the biotech companies seeing stocks soar this week. The company is a biopharmaceutical company that exploits anti-inflammatory properties of stem cells to develop therapies for serious medical conditions ... [Read]
Another Successful Healthcare Company: ChemoCentryx, Up 35%
The stock for ChemoCentryx Inc. (NASDAQ:CCXI) is on the rise, in the form of a 35% increase. This is only some of the good news for the company, which has just received two massive milestone ... [Read]
Biotechnology Stocks On The Rise, Ampliphi Biosciences Corp Makes A 16% Rally After Clinical Treatment Success
Biotechnology stocks are doing extremely well on the exchanges today, as a few biotech companies around the world announced clinical trial successes this morning. AmpliPhi Biosciences Corp. (AMX:APHB) has shown a large rally, as the ... [Read]
Successful Stem Cell Breakthrough Launches Cellect Biotechnology Ltd Stock Up Nearly 50%
Cellect Biotechnology Ltd. (NASDAQ:APOP) is having a great start on the trading floor this morning after announcing the breakthrough results of its clinical stem cell trial. The Israeli based company has stated that it has ... [Read]
Spark Therapeutics Prices Genetic Treatment at $850,000 and Stock Still Managed to Climb
Spark Therapeutics Inc. (NASDAQ:ONCE) has finally released the price of its much-anticipated gene-therapy treatment for a rare form of genetic blindness and, while the price is lower than originally expected, it’s still a mighty steep ... [Read]
Biotechnology the Market to Watch: The Top Two Percent Gainers on Nasdaq Today
Biotechnology was the winner today on the Nasdaq exchange, with two biotech companies ranking as number one and two for the top percentage gainers for the day. Neuralstem, Inc. Neuralstem, Inc. (NASDAQ:CUR) is a biotech ... [Read]
Midatech Pharma Closes At 75% Over Previous Close – Will the Stock Continue to Rise?
Midatech Pharma Plc (NASDAQ:MTP) closed on Tuesday’s market at $1.47, which was up $0.63, or 75%, from the previous closing price of $0.84, giving the company its first stock hike since November 2017. The company ... [Read]
Ignyta Inc. Investigation Continues
When Ignyta Inc. (NASDAQ:RXDX) was bought by Roche Holding Ltc (OTCQX:RHHBF), the December 22 news brought on a huge spike in Ignyta’s stock price, which went from $15.55 to $26.85 that day. But it also ... [Read]
BrainStorm Cell Therapeutics Stock Up Almost 30% After Company Sends Out Positive Letter to Shareholders
Considering today is the last trading day of the year, and BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) is one of the market’s trending tickers of the day, I think it’s safe to say that the New ... [Read]
Atara Biotherapeutics Gets FDA Approval and Stock Climbs Over 20%
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) has been having a good day today! The stock peaked this morning at $21.80 and has since leveled off a bit. Currently, the stock is trading at $18.55, putting it up ... [Read]